Clinical Trial Update: Head-to-Head Study of Etelcalcetide (AMG 416) and Cinacalcet [Phase 3]

View source ↗

Summary

Phase 3 head-to-head trial comparing etelcalcetide to cinacalcet in patients with secondary hyperparathyroidism and chronic kidney disease has completed with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperparathyroidism

Drugs mentioned

• Etelcalcetide (etelcalcetide)
• cinacalcet (cinacalcet hydrochloride)

Snippet

Sponsor: Amgen | Conditions: Secondary Hyperparathyroidism, Chronic Kidney Disease | Phase 3 | Status: COMPLETED | Results posted: 2017-02-08